fusidic acid has been researched along with Sclerosis, Systemic in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (50.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Coskun, BK; Kaya, A; Ozgocmen, S | 1 |
| Mozdzanowska, K; Mozdzanowski, J; Rubisz-Brzezińska, J; Zebracka, T | 2 |
| Christiansen, K | 1 |
1 review(s) available for fusidic acid and Sclerosis, Systemic
| Article | Year |
|---|---|
Fusidic acid non-antibacterial activity.
Topics: Acquired Immunodeficiency Syndrome; Animals; Anti-HIV Agents; Behcet Syndrome; Crohn Disease; Cytokines; Diabetes Mellitus, Type 1; Fusidic Acid; Humans; Immunosuppressive Agents; In Vitro Techniques; Mice; Psoriasis; Scleroderma, Systemic; Shock, Septic; Transplantation Immunology; Uveitis | 1999 |
1 trial(s) available for fusidic acid and Sclerosis, Systemic
| Article | Year |
|---|---|
[Therapeutic trial with fucidin in systemic scleroderma].
Topics: Adolescent; Adult; Amino Acids; Clinical Trials as Topic; Female; Fusidic Acid; Humans; Male; Middle Aged; Scleroderma, Systemic; Time Factors | 1984 |
2 other study(ies) available for fusidic acid and Sclerosis, Systemic
| Article | Year |
|---|---|
Topical lidocaine helps reduce pain of digital ulcers in systemic sclerosis (scleroderma).
Topics: Administration, Oral; Administration, Topical; Anesthetics, Local; Anti-Infective Agents; Ciprofloxacin; Drug Therapy, Combination; Female; Fusidic Acid; Humans; Lidocaine; Middle Aged; Pain; Scleroderma, Systemic; Skin Ulcer; Treatment Outcome | 2006 |
Treatment of systemic scleroderma with fucidine with regard to some free amino acids contents before and after therapy.
Topics: Adolescent; Adult; Amino Acids; Female; Fusidic Acid; Humans; Middle Aged; Scleroderma, Systemic | 1984 |